Hingiphar SA
Hingiphar reported total assets of €1.20m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Hingiphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hingiphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 68,949 € | ||||
| Equity | 969,913 € | ||||
| Cash | 904,554 € | ||||
| EBITDA | 113,855 € | ||||
| Total assets | €1.20m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 30 May 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Hingiphar's financial analysis
- Solvency80.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hingiphar
Hingiphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0460.756.730
- VAT number
- BE0460756730
- Peppol
- Registered · 0208:0460756730 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 May 1997
- Registered office
- 1910 Kampenhout
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Hingiphar (SA) has been based in Kampenhout since 1997, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 68,949 € and equity of 969,913 €; its revenue is not published. Its solvency stands at 80.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hingiphar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Sil Van Dijck Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet €1.20m
- Jolypharma Retail sale of pharmaceutical products Riemst · balance sheet €1.20m
- Pharmacie Dewaele-Witdouck Retail sale of pharmaceutical products Frasnes-lez-Anvaing · balance sheet €1.20m
- Hulspharma Retail sale of pharmaceutical products Hulshout · balance sheet €1.20m
- Diximo Retail sale of pharmaceutical products Ferrières · balance sheet €1.20m
- Dalemans Retail sale of pharmaceutical products Buggenhout · balance sheet €1.20m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
- Aa.Pharma Turnhout Retail sale of pharmaceutical products Turnhout · balance sheet €1.21m
Frequently asked questions about Hingiphar
What is the revenue of Hingiphar?
Hingiphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hingiphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0460756730 for Hingiphar, if the company is VAT-registered. Its company number (CBE) is 0460.756.730.
Where is the registered office of Hingiphar?
According to the CBE register, the registered office of Hingiphar is in 1910 Kampenhout.
What is the equity of Hingiphar?
At the close of the 2025 financial year, the equity of Hingiphar amounts to 969,913 €, a solvency of 80.7% of total assets.
Who manages Hingiphar?
The register lists 3 active mandates at Hingiphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hingiphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →